scholarly journals Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population

2021 ◽  
Vol Volume 15 ◽  
pp. 463-470
Author(s):  
Julia Berman ◽  
Victoria Furer ◽  
Mark Berman ◽  
Ofer Isakov ◽  
Devy Zisman ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Life Experience ◽  
Real Life ◽  
Resistant Population

Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience

2007 ◽  
Vol 67 (5) ◽  
pp. 717-719 ◽  
Author(s):  
L C Coates ◽  
L S Cawkwell ◽  
N W F Ng ◽  
A N Bennett ◽  
D J Bryer ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Life Experience ◽  
Real Life ◽  
Sustained Response

PsART-ID inception cohort: clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis

Rheumatology ◽  
2020 ◽  
Author(s):  
Gizem Ayan ◽  
Sibel Zehra Aydin ◽  
Gezmis Kimyon ◽  
Cem Ozisler ◽  
Ilaria Tinazzi ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Clinical Characteristics ◽  
Life Experience ◽  
Real Life ◽  
Treatment Strategies ◽  
Inception Cohort ◽  
Disease Pattern ◽  
Involvement Rate ◽  
Axial Involvement ◽  
Nail Involvement

Abstract Objectives Our aim is to understand clinical characteristics, real-life treatment strategies, outcomes of early PsA patients and determine the differences between the inception and established PsA cohorts. Methods PsArt-ID (Psoriatic Arthritis- International Database) is a multicentre registry. From that registry, patients with a diagnosis of PsA up to 6 months were classified as the inception cohort (n==388). Two periods were identified for the established cohort: Patients with PsA diagnosis within 5–10 years (n = 328), ≥10 years (n = 326). Demographic, clinical characteristics, treatment strategies, outcomes were determined for the inception cohort and compared with the established cohorts. Results The mean (s.d.) age of the inception cohort was 44.7 (13.3) and 167/388 (43.0%) of the patients were male. Polyarticular and mono-oligoarticular presentations were comparable in the inception and established cohorts. Axial involvement rate was higher in the cohort of patients with PsA ≥10 years compared with the inception cohort (34.8% vs 27.7%). As well as dactylitis and nail involvement (P = 0.004, P = 0.001 respectively). Both enthesitis, deformity rates were lower in the inception cohort. Overall, 13% of patients in the inception group had a deformity. MTX was the most commonly prescribed treatment for all cohorts with 10.7% of the early PsA patients were given anti-TNF agents after 16 months. Conclusion The real-life experience in PsA patients showed no significant differences in the disease pattern rates except for the axial involvement. The dactylitis, nail involvement rates had increased significantly after 10 years from the diagnosis and the enthesitis, deformity had an increasing trend over time.

scholarly journals Apremilast generic for the treatment of active psoriatic arthritis: A single-center real-life experience from India

2020 ◽  
Vol 15 (1) ◽  
pp. 46
Author(s):  
Dhiraj Dhoot ◽  
Sanjiv Amin ◽  
Aneesa Kapadia ◽  
Hanmant Barkate
Keyword(s):  
Psoriatic Arthritis ◽  
Life Experience ◽  
Real Life ◽  
Single Center

Treatment response, drug survival and safety of anti-tumour necrosis factor α therapy in 193 patients with psoriatic arthritis: A twelve-year “real life” experience

2015 ◽  
Vol 82 (1) ◽  
pp. 31-37 ◽  
Author(s):  
Anne-Sophie Soubrier ◽  
Peggy Bele-Philippe ◽  
Bernard Cortet ◽  
Nassima Ramdane-Sebbane ◽  
Marie-Astrid Bacle-Boutry ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Treatment Response ◽  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Life Experience ◽  
Real Life ◽  
Tumour Necrosis Factor Α ◽  
Drug Survival ◽  
Factor Α ◽  
Necrosis Factor

scholarly journals Apremilast for the treatment of active psoriatic arthritis: a single-centre real-life experience

Rheumatology ◽  
2017 ◽  
Vol 57 (3) ◽  
pp. 578-580 ◽  
Author(s):  
Giuseppina Abignano ◽  
Nafisa Fadl ◽  
Mira Merashli ◽  
Claire Wenham ◽  
Jane Freeston ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Life Experience ◽  
Real Life ◽  
Single Centre

Use of nintedanib for the treatment of idiopathic pulmonary fibrosis: multi-centre real life experience in Germany

Pneumologie ◽  
2016 ◽  
Vol 70 (S 01) ◽  
Author(s):  
F Bonella ◽  
M Kreuter ◽  
L Hagmeyer ◽  
C Neurohr ◽  
K Milger ◽  
...  
Keyword(s):  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Life Experience ◽  
Real Life
Sign in / Sign up

Export Citation Format

Share Document